LCAR-T2C CAR-T Cells in Relapsed or Refractory CD4+ T-cell Lymphoma
Clinical trial NCT04219319 · TERMINATED
Trial details
- NCT number
- NCT04219319
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-15
- Primary completion
- 2022-07-20
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.